Neurogene Inc. (NGNE) News
Track canonical SquawkNews coverage tagged to NGNE, Neurogene Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Neurogene shares are trading lower after the company announced a proposed public offering.
Neurogene shares are trading lower after the company announced a proposed public offering.
EQUITY | Jun 30, 2026, 08:04 PM UTC
L
Neurogene Reveals Proposed Public Offering; No Size Disclosed
Neurogene Inc. (NASDAQ: NGNE ), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that it has commenced a public of
EQUITY | Jun 30, 2026, 08:02 PM UTC